Glaxo and Astra to show EU pharma outshining U.S.
The U.S. drug sector is licking its wounds following Thursday's profit slump at Pfizer, the world's biggest pharmaceuticals company, but the picture is very different in Europe. Strong third-quarter results expected next week from GlaxoSmithKline (GSK.L: Quote, Profile, Research) and AstraZeneca (AZN.L: Quote, Profile, Research) will, once again, show European companies outshining their U.S. rivals, according to industry analysts.
No comments:
Post a Comment